Literature DB >> 23900885

Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1.

Zhifeng Peng1, Jiefei Li, Yun Li, Xuan Yang, Sujuan Feng, Song Han, Junfa Li.   

Abstract

Understanding the molecular mechanism of cerebral hypoxic preconditioning (HPC)-induced endogenous neuroprotection may provide potential therapeutic targets for ischemic stroke. By using bioinformatics analysis, we found that miR-181b, one of 19 differentially expressed miRNAs, may target aconitate hydratase (ACO2), heat shock protein A5 (HSPA5), and ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) among 26 changed protein kinase C isoform-specific interacting proteins in HPC mouse brain. In this study, the role of miR-181b in oxygen-glucose deprivation (OGD)-induced N2A cell ischemic injury in vitro and mouse middle cerebral artery occlusion (MCAO)-induced cerebral ischemic injury in vivo, and its regulation of ACO2, HSPA5, and UCHL1 were further determined. We found that miR-181b expression levels significantly decreased in mouse brain following MCAO and in OGD-treated N2A cells. Up- and downregulation of miR-181b by transfection of pre- or anti-miR-181b could negatively regulate HSPA5 and UCHL1 (but not ACO2) protein levels as well as N2A cell death and programmed cell death in OGD-treated N2A cells. By using a T7 promoter-driven control dual luciferase assay, we confirmed that miR-181b could bind to the 3'-untranslated rergions of HSPA5 and UCHL1 mRNAs and repress their translations. miR-181b antagomir reduced caspase-3 cleavage and neural cell loss in cerebral ischemic cortex and improved neurological deficit of mice after MCAO. In addition, HSPA5 and UCHL1 short interfering RNAs (siRNAs) blocked anti-miR-181b-mediated neuroprotection against OGD-induced N2A cell injury in vitro. These results suggest that the downregulated miR-181b induces neuroprotection against ischemic injury through negatively regulating HSPA5 and UCHL1 protein levels, providing a potential therapeutic target for ischemic stroke.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  hypoxia/ischemia; hypoxic preconditioning; miRNA; protein kinase C; stroke

Mesh:

Substances:

Year:  2013        PMID: 23900885     DOI: 10.1002/jnr.23255

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  50 in total

1.  Nicotinamide Mononucleotide Adenylyltransferase 1 Protects Neural Cells Against Ischemic Injury in Primary Cultured Neuronal Cells and Mouse Brain with Ischemic Stroke Through AMP-Activated Protein Kinase Activation.

Authors:  Jia Liang; Peng Wang; Jia Wei; Cuifen Bao; Donghe Han
Journal:  Neurochem Res       Date:  2015-04-05       Impact factor: 3.996

2.  CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury.

Authors:  Keri B Vartanian; Hugh D Mitchell; Susan L Stevens; Valerie K Conrad; Jason E McDermott; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-12       Impact factor: 6.200

3.  MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.

Authors:  Anna Maria Pierdomenico; Antonio Recchiuti; Felice Simiele; Marilina Codagnone; Veronica Cecilia Mari; Giovanni Davì; Mario Romano
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

Review 4.  The role of non-coding RNAs in neuroprotection and angiogenesis following ischemic stroke.

Authors:  Elaheh Heydari; Masoumeh Alishahi; Farhoodeh Ghaedrahmati; William Winlow; Seyed Esmaeil Khoshnam; Amir Anbiyaiee
Journal:  Metab Brain Dis       Date:  2019-08-24       Impact factor: 3.584

5.  microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke.

Authors:  Fatiha Tabet; Seyoung Lee; Wanying Zhu; Michael G Levin; Cynthia L Toth; Luisa F Cuesta Torres; Antony Vinh; Hyun Ah Kim; Hannah X Chu; Megan A Evans; Meaghan E Kuzmich; Grant R Drummond; Alan T Remaley; Kerry-Anne Rye; Christopher G Sobey; Kasey C Vickers
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-11       Impact factor: 6.200

6.  Overexpression of HIF-1α protects PC12 cells against OGD/R-evoked injury by reducing miR-134 expression.

Authors:  Hongliang Zhang; Xianming Liu; Fengyu Yang; Dekui Cheng; Wei Liu
Journal:  Cell Cycle       Date:  2020-04-08       Impact factor: 4.534

Review 7.  Non-coding RNAs and neuroprotection after acute CNS injuries.

Authors:  Raghavendar Chandran; Suresh L Mehta; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2017-01-26       Impact factor: 3.921

8.  MicroRNA Expression in the Glaucomatous Retina.

Authors:  Hari Jayaram; William O Cepurna; Elaine C Johnson; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

9.  miR-134 regulates ischemia/reperfusion injury-induced neuronal cell death by regulating CREB signaling.

Authors:  Weidong Huang; Xiaobin Liu; Jie Cao; Facai Meng; Min Li; Bo Chen; Jie Zhang
Journal:  J Mol Neurosci       Date:  2014-10-16       Impact factor: 3.444

10.  miR-525-5p inhibits ADAMTS13 and is correlated with Ischemia/reperfusion injury-induced neuronal cell death.

Authors:  Liyan Zhao; Cong Hua; Yunqian Li; Qingqing Sun; Wei Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.